Skip to content
ESE logo
Partner Guideline: International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023

Authors

Helena J Teede, Chau Thien Tay, Joop J E Laven, Anuja Dokras, Lisa J Moran, Terhi T Piltonen, Michael F Costello, Jacky Boivin, Leanne M Redman, Jacqueline A Boyle, Robert J Norman, Aya Mousa, Anju E Joham on behalf of the International PCOS Network

Developed By:

The Centre for Research Excellence in Women’s Health in Reproductive Life (CRE WHiRL), in partnership with the American Society of Reproductive Medicine (ASRM), the Endocrine Society, the European Society of Endocrinology (ESE), and the European Society of Human Reproduction and Embryology (ESHRE), and in collaboration with professional societies and consumer advocacy groups internationally.

Introduction

Building on the 2018 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (PCOS), this guideline updates and expands clinical questions, aiming to ensure that women with PCOS receive optimal, evidence-based care that meets their needs and improves health outcomes. The guideline and translation programme were developed with full consumer participation at all stages including priority topics and outcomes for those with PCOS. 

European Journal of Endocrinology, Volume 189, Issue 2, August 2023, Pages G43–G64

Read the full Guideline

Related Resources

A number of additional resources were also made available.

Published
15/08/2023
Tags
Guidelines , Joint Guideline , Reproductive and Developmental Endocrinology ,
Other Publications